Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 3
1(33.3%)
3Total
N/A(2)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT07555067Enrolling By Invitation

Comparison Between Velys J&J Robotic-assisted and Cori S&N Robotic-assisted Total Knee Arthroplasty

Role: lead

NCT05527704Phase 3Active Not Recruiting

the Inhaled β2-adrenergic Receptor Agonist for Transient Tachypnoea of the Newborn (the REFSAL Trial)

Role: collaborator

NCT07190092Not ApplicableRecruiting

Deep Anterior Cerebellar Stimulation in Treatment of Poststroke Spasticity and Motor Function Impairment.

Role: lead

NCT03948802Completed

Evaluation of IL-33 in Patients With the Acute Ischemic Stroke

Role: lead

NCT05700773Recruiting

The Relationship Between Myonectin Concentration and the Course of ST-segment Elevation Myocardial Infarction

Role: collaborator

NCT03957395Not ApplicableUnknown

Comparison of Effectiveness of Tonic, High Frequency and Burst Spinal Cord Stimulation in Chronic Pain Syndromes

Role: lead

NCT03948399Unknown

The Prevalence of a Low Ankle-Brachial Index in Acute Cerebral Ischemia.

Role: lead

All 7 trials loaded